
Home » Rosetta Launches Collaborations to Advance Fluids-Based Diagnostic Tests
Rosetta Launches Collaborations to Advance Fluids-Based Diagnostic Tests
February 1, 2011
Rosetta Genomics, Ltd. announced that it has signed two new agreements for the development and validation of microRNA-based diagnostics for various indications related to its Gen 3 products.
iStockAnalyst
iStockAnalyst
Upcoming Events
-
19Jan
-
21Jan
-
26Jan
-
27Jan
-
27Jan
-
09Feb